Hepatocellular carcinoma is the most common type of malignant tumour in Asia. Treatment
is decided according to the staging system with information on tumour burden and liver …

Hepatocellular carcinoma (HCC), the fifth most common cancer that predominantly occurs in
liver cirrhosis patients, requires staging systems to design treatments. The barcelona clinic …

Objective: We sought to determine the factors associated with survival after recurrence of
hepatocellular cancer (HCC) after resection and the outcome of our prospectively applied …

Background For patients with hepatocellular carcinoma (HCC) with portal vein tumor
thrombosis (PVTT), the survival benefit of transarterial chemoembolization (TACE) …

Purpose To determine the efficacy and safety of transarterial chemoembolization (TACE) in
patients with hepatocellular carcinoma (HCC) and main portal vein (MPV) invasion …

Background & Aims Transarterial chemoembolization (TACE) is the standard of care for
intermediate stage hepatocellular carcinoma (HCC) and it is the most commonly used …

Drug-eluting bead transarterial chemoembolization (DEB-TACE) is a relative new
endovascular treatment based on the use of microspheres to release chemotherapeutic …

Purpose To compare the efficacies of transarterial chemoembolization (TACE) and sorafenib
in patients with advanced-stage hepatocellular carcinoma (HCC). Materials and Methods …

AIM: To compare radiofrequency ablation (RFA) and transcatheter arterial
chemoembolization (TACE) with RFA monotherapy in hepatocellular carcinoma (HCC) …

Background Although transarterial chemoembolization (TACE) has been used extensively
for advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT), no …